Organisation paid for research Program year 2025 Source: CMS Open Payments

Novum Research LLC

Neither a doctor nor a teaching hospital

Research payments

$208,060

86 payments

Through program year 2025, Novum Research LLC is reported as receiving $208,060 in research payments, across 86 payments.

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$208,060	86

Breakdown

Who paid Research payments · program year 2025

AbbVie, Inc. $208,060 86 payments

Studies the money was for Research payments · program year 2025

A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease $86,865 52 payments
M23-784 - A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease $57,110 22 payments
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab (REVAMP) $40,393 6 payments
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn s Disease (Target CD) $16,900 2 payments
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn s Disease (Target CD) $4,697 1 payment
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease $2,094 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.